佛山市企业创新|创业|孵化|辅导-51亿企创平台为粤港澳大湾区、珠三角、长三角、7个直辖市、7个经济特区、全国省会城市的企业提供工商注册、项目申报、人才引进、创赛活动、代理记账、知识产权、系统开发、企业辅导、技术转移、企业办公用品等服务，从项目孵化、企业入驻、经营发展、上市，一站式企业全生命周期赋能服务平台。

敖汉谷雨农产品销售有限公司成立于2015年1月，以销售敖汉小米，敖汉杂豆等有机农产品为主。公司产品全部原产地发货，服务全国。

该站点未添加描述description...

中国税务网,中国税务杂志社,中国税务,中国税收

该站点未添加描述description...

佛山好音声学材料有限公司,好音声学是一家专注于声学吸音隔音装饰材料和活动隔断,可提供设计参考,厂家直销一站式,生产、施工一体的吸音材料供应公司。

该站点未添加描述description...

鸿盛广达【浪潮服务器官方授权】四川成都服务器代理一级总代理经销商,成都浪潮服务器总代理联系电话:13981931555同微信号。

宏众百德拥有自主研发的Algae-Hub藻类人工智能分析仪,自主构建的海量浮游植物形态学和DNA数据库,提供藻类、生物监测和环境微生物研究领域内的高通量测序服务、微生物多组学分析服务.产品主要有:藻类分析仪,藻类鉴定仪,藻类计数仪,藻类监测仪,藻类监测,藻类仪器,藻类识别,藻类计数,藻类自动分析仪,藻类分类计数仪,藻类鉴定计数仪,藻类在线计数仪,藻类智能鉴定仪,藻类分析检测仪,藻类在线监测仪,野外藻类分析仪,藻类自动定量分析仪,浮游植物监测,浮游植物仪器,浮游植物识别,浮游植物计数,浮游植物分析仪,浮游植物快速检测仪,浮游植物智能鉴定仪.

该站点未添加描述description...

该站点未添加描述description...

WestVacBiopharmaisfoundedbyAcademicianWeiYuquanfromWestChinaHospitalofSichuanUniversity,togetherwith10scientistsfromStateKeyLaboratoryofBiotherapy(SKLB).ItsheadquarterislocatedintheInternationalBio-Town,Chengdu.TheCEOofWestVacBiopharmaisProf.WeiYuquan,whoistheAcademicianofChineseAcademyofSciencesaswellastheDirectorofStateKeyLaboratoryofBiotherapy.WestVaciscommittedtoexploringthelatestbiotherapytechnologiesformajordiseases,includinginfectiousdiseases,malignanttumors,cardiovasculardiseases,andsoon.IthasattachedgreatimportanceintheResearchandDevelopment(R&D)ofCOVID-19vaccineespeciallyandbuildingaCOVID-19vaccineproductionplatform.StateKeyLaboratoryofBiotherapy(SKLB)wasestablishedbytheMinistryofSciencesandTechnologyofChinain2005andbecameoneoftheNationalR&DPlatformsforNovelDrugsfoundedbytheMinistriesofSciencesandTechnologyaswellasthatofHealthofChinain2008.ItisalsosupportedbyNationalCollaborativeInnovationProgramandhasbecometheNationalCollaborativeInnovationCenterforBiotherapysince2013.WestChinaHospitalofSichuanUniversity，foundedin1892,istheNationalCenterforDiagnosisandTreatmentofSevereandCriticalDiseasesinWesternChina.Itisalsotheworld’slargestcomprehensivehospitalcomplexlocatedinonecampusarea.RelyingonthemedicalresourcesofStateKeyLaboratoryofBiotherapyandWestChinaMedicalCenter,WestVachasadoptedrecombinantproteinmethodologytodeveloptheCOVID-19vaccine.Becauseofthesafetyoftheproteinvaccine,itisalsotheonlyCOVID-19vaccineapprovedfortheuseinchildrenover3yearsoldinChina.ThevaccinewasapprovedbytheNationalMedicalProductsAdministrationforclinicaltrialsonAugust21,2020.PhaseI/IIclinicaltrialshavebeencompleted,andphaseIIIclinicaltrialsarebeingcarriedoutinNepal,Kenya,Japanandothercountries.Thevaccinetargetsthespikeproteinbindingdomain(S-RBD)ofSARS-CoV-2,producingneutralizingantibodiestoblockCOVID-19infectionofhumancells.TheresultwaspublishedonNature,theworld’sfamousscientificjournalonJuly29th,2020.IthasalsobeenthefirstpaperofCOVIDvaccinepublishedbyNaturesincethepandemicoutbreak.TheS-RBDgeneoftheCOVID-19virusisintroducedintotheinsectcells,whichwereusedasafactorytoproducehigh-qualityrecombinantvaccineproteinandthendoesrefinedpurification.Suchtechnologyiseasytobemass-producedandbroughttothemarket.WestVacBiopharmaiscommittedtobecomingtheworld`sleadingvaccineandimmunotherapyplatform.